Abstract
The structural basis of sequence-selective DNA recognition by Fe-bleomycin (Fe-BLM) has been studied by the use of BLM congeners in which the two functional domains are separated by spacers of variable length. Fe-bleomycin has also been shown to recognize and cleave RNA, which may constitute a new target of therapeutic importance for BLM.
Original language | English (US) |
---|---|
Pages (from-to) | 2463-2474 |
Number of pages | 12 |
Journal | Tetrahedron |
Volume | 47 |
Issue number | 14-15 |
DOIs | |
State | Published - 1991 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry